Bee: Thanks for your response... in following many clinical trials I have never seen a primary endpoint that isn't well defined... this endpoint, to me, looks like it may have some "decisions" involved rather that just pure statistics... let's hope the data is so compelling it will be easy for regulators to stamp it approved...